APP and early-onset autosomal dominant Alzheimer disease: Additionally, we utilized a Drosophila Alzheimer’s disease (AD) model overexpressing human Abeta peptide in the central nervous system [22–24] in the screening process, and found that the screening portfolios of the herbal extracts were quite different from control files.